AI assistant
INSMED Inc — Director's Dealing 2025
Dec 19, 2025
30150_dirs_2025-12-19_09bfc594-6c41-40c7-94f7-fc901b71b902.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-12-18
Reporting Person: Lewis William (Director, Chair and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-18 | Common Stock | M | 4440 | $17.16 | Acquired | 308351 | Direct |
| 2025-12-18 | Common Stock | M | 6259 | $30.46 | Acquired | 314610 | Direct |
| 2025-12-18 | Common Stock | S | 350 | $162.26 | Disposed | 314260 | Direct |
| 2025-12-18 | Common Stock | S | 1465 | $163.19 | Disposed | 312795 | Direct |
| 2025-12-18 | Common Stock | S | 447 | $164.24 | Disposed | 312348 | Direct |
| 2025-12-18 | Common Stock | S | 697 | $165.21 | Disposed | 311651 | Direct |
| 2025-12-18 | Common Stock | S | 1783 | $166.60 | Disposed | 309868 | Direct |
| 2025-12-18 | Common Stock | S | 1431 | $167.29 | Disposed | 308437 | Direct |
| 2025-12-18 | Common Stock | S | 2175 | $168.54 | Disposed | 306262 | Direct |
| 2025-12-18 | Common Stock | S | 1938 | $169.58 | Disposed | 304324 | Direct |
| 2025-12-18 | Common Stock | S | 362 | $170.26 | Disposed | 303962 | Direct |
| 2025-12-18 | Common Stock | S | 51 | $171.20 | Disposed | 303911 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-18 | Stock Option (right to buy) | $17.16 | M | 4440 | Disposed | 2027-05-17 | Common Stock (4440) | Direct |
| 2025-12-18 | Stock Option (right to buy) | $30.46 | M | 6259 | Disposed | 2028-01-04 | Common Stock (6259) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 233924 | Indirect |
| Common Stock | 50500 | Indirect |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 350 shares sold at prices ranging from $161.72 to $162.69 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 1,465 shares sold at prices ranging from $162.72 to $163.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: This is the weighted average sales price representing 447 shares sold at prices ranging from $163.75 to $164.73 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: This is the weighted average sales price representing 697 shares sold at prices ranging from $164.83 to $165.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F6: This is the weighted average sales price representing 1,783 shares sold at prices ranging from $166.00 to $166.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F7: This is the weighted average sales price representing 1,431 shares sold at prices ranging from $167.00 to $167.95 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F8: This is the weighted average sales price representing 2,175 shares sold at prices ranging from $168.01 to $169.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F9: This is the weighted average sales price representing 1,938 shares sold at prices ranging from $169.01 to $170.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F10: This is the weighted average sales price representing 362 shares sold at prices ranging from $170.02 to $170.91 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F11: This is the weighted average sales price representing 51 shares sold at prices ranging from $171.09 to $171.35 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F12: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.